383 related articles for article (PubMed ID: 20674321)
41. Altered immune responses in patients with chronic mucocutaneous candidiasis.
Khosravi AR; Shokri H; Darvishi S
J Mycol Med; 2014 Jun; 24(2):135-40. PubMed ID: 24582143
[TBL] [Abstract][Full Text] [Related]
42. Altered, but not diminished specific T cell response in chronic mucocutaneous candidiasis patients.
Eyerich K; Rombold S; Foerster S; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
Arch Dermatol Res; 2007 Dec; 299(10):475-81. PubMed ID: 17960405
[TBL] [Abstract][Full Text] [Related]
43. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis.
Lilic D; Gravenor I; Robson N; Lammas DA; Drysdale P; Calvert JE; Cant AJ; Abinun M
Infect Immun; 2003 Oct; 71(10):5690-9. PubMed ID: 14500490
[TBL] [Abstract][Full Text] [Related]
44. Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility.
Dhalla F; Fox H; Davenport EE; Sadler R; Anzilotti C; van Schouwenburg PA; Ferry B; Chapel H; Knight JC; Patel SY
Clin Exp Immunol; 2016 May; 184(2):216-27. PubMed ID: 26621323
[TBL] [Abstract][Full Text] [Related]
45. Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production.
Lilic D; Cant AJ; Abinun M; Calvert JE; Spickett GP
Clin Exp Immunol; 1996 Aug; 105(2):205-12. PubMed ID: 8706323
[TBL] [Abstract][Full Text] [Related]
46. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
[TBL] [Abstract][Full Text] [Related]
47. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
[TBL] [Abstract][Full Text] [Related]
48. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses.
Smeekens SP; Huttenhower C; Riza A; van de Veerdonk FL; Zeeuwen PL; Schalkwijk J; van der Meer JW; Xavier RJ; Netea MG; Gevers D
J Innate Immun; 2014; 6(3):253-62. PubMed ID: 23796786
[TBL] [Abstract][Full Text] [Related]
49. A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.
Nielsen J; Kofod-Olsen E; Spaun E; Larsen CS; Christiansen M; Mogensen TH
BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26494717
[TBL] [Abstract][Full Text] [Related]
50. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis.
Barnaba V; Zaccari C; Levrero M; Balsano F
Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525
[TBL] [Abstract][Full Text] [Related]
51. A novel gain-of-function STAT1 mutation resulting in basal phosphorylation of STAT1 and increased distal IFN-γ-mediated responses in chronic mucocutaneous candidiasis.
Martinez-Martinez L; Martinez-Saavedra MT; Fuentes-Prior P; Barnadas M; Rubiales MV; Noda J; Badell I; Rodríguez-Gallego C; de la Calle-Martin O
Mol Immunol; 2015 Dec; 68(2 Pt C):597-605. PubMed ID: 26514428
[TBL] [Abstract][Full Text] [Related]
52. Innate Error Immunities of the Th17 Immune Pathway Associated With Chronic Mucocutaneous Candidiasis: A Systematic Review.
Mirza VS; Zaino ML; Feldman SR
J Drugs Dermatol; 2023 Dec; 22(12):1197-1203. PubMed ID: 38051840
[TBL] [Abstract][Full Text] [Related]
53. Isolated Chronic Mucocutaneous Candidiasis due to a Novel Duplication Variant of IL17RC.
Noma K; Tsumura M; Nguyen T; Asano T; Sakura F; Tamaura M; Imanaka Y; Mizoguchi Y; Karakawa S; Hayakawa S; Shoji T; Hosokawa J; Izawa K; Ling Y; Casanova JL; Puel A; Tangye SG; Ma CS; Ohara O; Okada S
J Clin Immunol; 2023 Dec; 44(1):18. PubMed ID: 38129603
[TBL] [Abstract][Full Text] [Related]
54. Biallelic TRAF3IP2 variants causing chronic mucocutaneous candidiasis in a child harboring a STAT1 variant.
Blanco Lobo P; Lei WT; Pelham SJ; Guisado Hernández P; Villaoslada I; de Felipe B; Lucena JM; Casanova JL; Olbrich P; Puel A; Neth O
Pediatr Allergy Immunol; 2021 Nov; 32(8):1804-1812. PubMed ID: 34289170
[TBL] [Abstract][Full Text] [Related]
55. Candida-specific interferon-gamma deficiency and toll-like receptor polymorphisms in patients with chronic mucocutaneous candidiasis.
van der Graaf CA; Netea MG; Drenth IP; te Morsche RH; van der Meer JW; Kullberg BJ
Neth J Med; 2003 Nov; 61(11):365-9. PubMed ID: 14768719
[TBL] [Abstract][Full Text] [Related]
56. Transient abrogation of immunosuppression in a patient with chronic mucocutaneous candidiasis following vaccination with Candida albicans.
Burford-Mason AP; Matthews RC; Williams JR
J Infect; 1987 Mar; 14(2):147-57. PubMed ID: 2952735
[TBL] [Abstract][Full Text] [Related]
57. Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel
Erdős M; Jakobicz E; Soltész B; Tóth B; Bata-Csörgő Z; Maródi L
Front Immunol; 2020; 11():967. PubMed ID: 32547544
[TBL] [Abstract][Full Text] [Related]
58. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects.
Engelhardt KR; Grimbacher B
J Allergy Clin Immunol; 2012 Feb; 129(2):294-305; quiz 306-7. PubMed ID: 22284928
[TBL] [Abstract][Full Text] [Related]
59. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
[TBL] [Abstract][Full Text] [Related]
60. STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.
Hiller J; Hagl B; Effner R; Puel A; Schaller M; Mascher B; Eyerich S; Eyerich K; Jansson AF; Ring J; Casanova JL; Renner ED; Traidl-Hoffmann C
J Invest Dermatol; 2018 Mar; 138(3):711-714. PubMed ID: 29054602
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
